biopharma

Sanofi’s investment strategy for transitioning to a pure biopharma

Sanofi’s investment strategy for transitioning to a pure biopharma

admin November 9, 2024 0

In October 2023, Sanofi announced plans to separate its consumer health unit in 2024. Sanofi’s consumer health division, with flagship...

Read More

Investment Strategy

Elementum launches Enhanced Yield Strategy, expands collateralized reinsurance investment range

admin January 15, 2025 0

SNP Genotyping and Analysis Market Size to Worth USD 80.7 billion by 2030, Says Coherent Market Insight

SNP Genotyping and Analysis Market Size to Worth USD 80.7 billion by 2030, Says Coherent Market Insight

admin January 15, 2025 0

Budget 2025: Simplified capital gains tax, enhanced benefits on investors’ budget wish list

Budget 2025: Simplified capital gains tax, enhanced benefits on investors’ budget wish list

admin January 15, 2025 0

OTC Drugs, Medical Devices and Diagnostics Market Analysis and Key Player Shares to 2029, Featuring Haleon Group of Co., Kenvue, Sanofi, and Bayer Among Others

OTC Drugs, Medical Devices and Diagnostics Market Analysis and Key Player Shares to 2029, Featuring Haleon Group of Co., Kenvue, Sanofi, and Bayer Among Others

admin January 14, 2025 0

Top 5 Altcoins to Watch in 2025: Scaramucci’s Crypto Investment Strategy

Top 5 Altcoins to Watch in 2025: Scaramucci’s Crypto Investment Strategy

admin January 13, 2025 0